Literature DB >> 12012571

Friedrich Heinrich Lewy (1885-1950) and his work.

Bernd Holdorff1.   

Abstract

In 1912, Friedrich Heinrich Lewy first described the inclusion bodies named after him and seen in paralysis agitans (p.a.). Tretiakoff had found (1919) that the nucleus niger is most likely to be affected but in a subsequent large-scale series of post-mortem examinations (1923). Lewy was able to confirm this for a minority of cases only, with the exception of those that displayed postencephalitic Parkinsonism (and an unknown number of atypical Parkinson syndrome cases not identified until the 1960s). In a speculative paper (1932), he saw similarities between inclusion bodies in p.a. and viral diseases like lyssa and postulated a viral genesis of p.a. In a historical review of basal ganglia diseases (1942), he did not mention the putative significance of the inclusion bodies for the post-mortem diagnosis. It seems that their importance was seen only after Lewy's death, long after Tretiakoff's initial naming of the 'corps de Lewy'. Lewy, however, had already described their diffuse and cortical distribution (1923). An identification of diffuse Lewy body disease or dementia followed much later. Lewy's career in many diverse branches of neurology and internal medicine was strongly affected by World War I and the difficult situation faced by Jews in Germany. Shortly after the Neurological Institute was founded in Berlin in 1932 (as a clinic and research institute), he was forced, in 1933, to emigrate. His exile in England and the United States mirrors the fate of many German Jews and academics in the first half of the 20th century.

Entities:  

Mesh:

Year:  2002        PMID: 12012571     DOI: 10.1076/jhin.11.1.19.9106

Source DB:  PubMed          Journal:  J Hist Neurosci        ISSN: 0964-704X            Impact factor:   0.529


  20 in total

1.  Fritz Heinrich Lewy (1885-1950).

Authors:  Bernd Holdorff
Journal:  J Neurol       Date:  2006-05       Impact factor: 4.849

Review 2.  Neuropsychological characteristics of dementia with Lewy bodies and Parkinson's disease with dementia: differentiation, early detection, and implications for "mild cognitive impairment" and biomarkers.

Authors:  Alexander I Tröster
Journal:  Neuropsychol Rev       Date:  2008-03-06       Impact factor: 7.444

Review 3.  Implication of matrix metalloproteinases in regulating neuronal disorder.

Authors:  Abhishek Mukherjee; Snehasikta Swarnakar
Journal:  Mol Biol Rep       Date:  2015-01       Impact factor: 2.316

Review 4.  Centenary of Lewy bodies (1912-2012).

Authors:  Bernd Holdorff; Antonio M Rodrigues e Silva; Richard Dodel
Journal:  J Neural Transm (Vienna)       Date:  2013-03-02       Impact factor: 3.575

5.  Peroxidative aggregation of alpha-synuclein requires tyrosines.

Authors:  Alina Olteanu; Gary J Pielak
Journal:  Protein Sci       Date:  2004-09-30       Impact factor: 6.725

6.  Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction.

Authors:  Thomas G Beach; Charles H Adler; LihFen Lue; Lucia I Sue; Jyothi Bachalakuri; Jonette Henry-Watson; Jeanne Sasse; Sarah Boyer; Scophil Shirohi; Reed Brooks; Jennifer Eschbacher; Charles L White; Haru Akiyama; John Caviness; Holly A Shill; Donald J Connor; Marwan N Sabbagh; Douglas G Walker
Journal:  Acta Neuropathol       Date:  2009-04-28       Impact factor: 17.088

Review 7.  α-Synuclein elevation in human neurodegenerative diseases: experimental, pathogenetic, and therapeutic implications.

Authors:  Ayse Ulusoy; Donato A Di Monte
Journal:  Mol Neurobiol       Date:  2012-09-04       Impact factor: 5.590

8.  100 years of Lewy pathology.

Authors:  Michel Goedert; Maria Grazia Spillantini; Kelly Del Tredici; Heiko Braak
Journal:  Nat Rev Neurol       Date:  2012-11-27       Impact factor: 42.937

9.  Ubiquitin conjugation triggers misfolded protein sequestration into quality control foci when Hsp70 chaperone levels are limiting.

Authors:  Ayala Shiber; William Breuer; Michael Brandeis; Tommer Ravid
Journal:  Mol Biol Cell       Date:  2013-05-01       Impact factor: 4.138

10.  Concordance of psychiatric symptom ratings between a subject and informant, relevancy to post-mortem research.

Authors:  P M Thompson; C G Bernardo; D A Cruz; N S Ketchum; J E Michalek
Journal:  Transl Psychiatry       Date:  2013-01-15       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.